AN ISSUE OF DRUG INTERACTION IN CARDIOLOGICAL PRACTICE: WHAT SHALL PHYSICIAN BE AWARE OF?

AN ISSUE OF DRUG INTERACTION IN CARDIOLOGICAL PRACTICE: WHAT SHALL PHYSICIAN BE AWARE OF?

The article focuses on the results of data review obtained from accessible local and international sources concerning drug interaction and selection of drugs taking these data into account. The data provided on statins, angiotensine II receptors antagonists, acetylsalicylic acid and renin-angiotensi...

Full description

Bibliographic Details
Main Authors:	E. I. Tarlovskaya, N. A. Koziolova, A. I. Chesnikova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2015-12-01
Series:	Российский кардиологический журнал
Subjects:	drug interaction statins angiotensine ii receptor antagonists valsartan aspirin clopidogrel ace inhibitor
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/483

Similar Items

THE INFLUENCE OF LIFESTYLE ON THE EFFICACY AND SAFETY OF MEDICATIONS IN CARDIOLOGICAL PRACTICE: WHAT SHALL PHYSICIAN BE AWARE OF?
by: E. I. Tarlovskaya, et al.
Published: (2016-01-01)

Inflammation role in atrial fibrillation pathogenesis
by: A. I. Tarzimanova, et al.
Published: (1970-01-01)

Analytical methods for the determination of aspirin in its combinations with clopidogrel and some statins in medications for treatment of acute coronary syndromes (ACS)
by: Imad Abu Reid
Published: (2024-06-01)

Angiotensin-converting enzyme inhibitors, angiotensin-II-receptor antagonists and angiotensin-receptor blocker/neprilysin inhibitor utilization in heart failure patients: Sub-analysis of a nation-wide population-based study in the Czech Republic
by: Renata Aiglova, et al.
Published: (2022-09-01)

Real-world experience of clinical management with antiplatelet and lipid-lowering therapy in post acute coronary syndrome patients in Indian setting
by: M S Hiremath, et al.
Published: (2021-01-01)

NEW POSSIBILITIES OF STATIN THERAPY IN ARTERIAL HYPERTENSION
by: E. M. Khurs, et al.
Published: (2016-01-01)

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: N. F. Puchinian, et al.
Published: (2017-03-01)

ANGIOTENSIN II RECEPTOR ANTAGONISTS AND ACE INHIBITORS: OPTIMIZATION OF CHOICE FOR TREATMENT OF CARDIOVASCULAR DISEASES
by: E. M. Khurs, et al.
Published: (2016-01-01)

ROLE OF THE ANTIPLATELET DRUGS IN TREATMENT OF STABLE ANGINA: COMMON SENSE AND NON-RESOLVED ISSUES
by: V. V. Yakusevich, et al.
Published: (2015-07-01)

Comparison of effects of telmisartan versus valsartan on post-induction hypotension during noncardiac surgery: a prospective observational study
by: Chung-Sik Oh, et al.
Published: (2024-06-01)

PLACE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN ARTERIAL HYPERTENSION THERAPY
by: S. A. Boytsov, et al.
Published: (2016-01-01)

Pharmacodynamic effects of a new fixed-dose clopidogrel–aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial
by: Jin-Sin Koh, et al.
Published: (2017-02-01)

CARDIOVASCULAR PATIENT WITH STAGE 1-3 CHRONIC KIDNEY DISEASE: CONTEMPORARY CARDIONEPHROPROTECTION IN REAL CLINICAL PRACTICE
by: E. I. Tarlovskaya
Published: (2016-09-01)

Evaluation ofAaspirin, Clopidogrel or Their Combination In Hypertensive Patients
by: Fadia Y. Al-hamdani, et al.
Published: (2010-12-01)

The association of antiplatelet agents with mortality among patients with non–COVID-19 community-acquired pneumonia: a systematic review and meta-analysis
by: Sylvain A. Lother, et al.
Published: (2024-07-01)

RETRACTED: An objective: to lower blood pressure effectively and safely. How to do it in a rational and modern way?
by: O. V. Dralova, et al.
Published: (2022-12-01)

Renin-angiotensin and kallikrein-kinin systems in diabetic retinopathy
by: Igić Rajko
Published: (2019-01-01)

Effect of Low-dose, Enteric Coated Aspirin on Gastrointestinal Bleeding in Patients with Coronary Artery Disease
Published: (2008-09-01)

Antiplatelet treatment patterns and outcomes of secondary stroke prevention in the United States
by: Ellen O'Brien, et al.
Published: (2023-02-01)

Assessment of efficacy of single dose acetylsalicylic acid over a 24-hour period
by: Reşat Mehmet Baha, et al.
Published: (2015-07-01)

Cardiovascular Prevention in People Living With HIV
by: Johanne Silvain, MD, PhD, et al.
Published: (2022-11-01)

Antiplatelet Effects of Clopidogrel Vs Aspirin in Virologically Controlled HIV
by: Emanuela Marcantoni, PhD, et al.
Published: (2022-11-01)

Angiotensin II type 1 receptor antagonists and ACE inhibitors in the regulation of hemodynamics and renin-angiotensin-aldosterone system activity: focus on the organ protection
by: M. L. Maksimov, et al.
Published: (2010-04-01)

Age-related reduction in brain ACE-2 is not exacerbated by Alzheimer’s disease pathology in mouse models of Alzheimer’s disease
by: Robert MacLachlan, et al.
Published: (2023-01-01)

Valsartan Reduced Atrial Fibrillation Susceptibility by Inhibiting Atrial Parasympathetic Remodeling through MAPKs/Neurturin Pathway
by: Lei Liu, et al.
Published: (2015-07-01)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
by: O D Ostroumova, et al.
Published: (2016-12-01)

The choice of antihypertensive therapy in correction of cognitive impairments and prevention of dementia: possibilities of valsartan and fixed-dose combination of valsartan and hydrochlorothiazide
by: Ostroumova O.D., et al.
Published: (2016-12-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

AGTR1 A1166C gene polymorphism is associated with the effectiveness of valsartan monotherapy in Chinese patients with essential hypertension: A retrospective analysis
by: Hanzhong Yu, et al.
Published: (2024-09-01)

SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY)
by: S. B. Fitilev, et al.
Published: (2017-05-01)

How to undertake procedures while on antiplatelet agents: a hematologist's view
by: Dawn Swan, et al.
Published: (2024-08-01)

Effects of thienopyridine class antiplatelets on bleeding outcomes following robot-assisted radical prostatectomy
by: Masashi Kubota, et al.
Published: (2024-03-01)

Aspirin use is safe in patients undergoing transbronchial lung cryobiopsy
by: Lilach Israeli-Shani, et al.
Published: (2023-12-01)

Targeting Platelet Activation Pathways to Limit Tumour Progression: Current State of Affairs
by: Kutlwano R. Xulu, et al.
Published: (2022-12-01)

Risk of inpatient epistaxis admission related to oral anticoagulation medication use
by: Margaret B. Mitchell, et al.
Published: (2023-08-01)

Pharmacokinetics and relative bioavailability of fixed-dose combination of clopidogrel and aspirin versus coadministration of individual formulations in healthy Korean men
by: Choi HK, et al.
Published: (2016-10-01)

ARB Compared with non-ARB in Preventing Cardiac Events in High Risk Hypertensive Patients: An Evidence Based Case Report
by: Alvin Nursalim, et al.
Published: (2013-06-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)

Bioanalytical HPLC method development for simultaneous determination of valsartan and co-administered clopidogrel bisulfate and fenofibrate in stroke prevention in raw materials, spiked human plasma and tablets
by: Ragab Gamal H., et al.
Published: (2018-12-01)

ACE INHIBITORS AND ANGIOTENSIN II RECEPTOR BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASE: WHAT TO CHOOSE?
by: K. A. Ghyamdzhyan, et al.
Published: (2022-12-01)